Topics

Merck & Co. raises full-year guidance as quarterly sales of Keytruda top $3 billion for first time http://www.firstwordpharma.com/node/1677100  $MRK

08:31 EDT 29 Oct 2019 | FirstWord Pharma

Merck & Co. raises full-year guidance as quarterly sales of Keytruda top $3 billion for first time http://www.firstwordpharma.com/node/1677100 

Original Article: Merck & Co. raises full-year guidance as quarterly sales of Keytruda top $3 billion for first time http://www.firstwordpharma.com/node/1677100  $MRK

NEXT ARTICLE

More From BioPortfolio on "Merck & Co. raises full-year guidance as quarterly sales of Keytruda top $3 billion for first time http://www.firstwordpharma.com/node/1677100  $MRK"

Quick Search

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...